Trial Profile
Phase Ib dose-finding and pharmacokinetics study of CPT injection in MM
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jul 2019
Price :
$35
*
At a glance
- Drugs Aponermin (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 21 May 2012 Actual end date (20 Nov 2010) added as reported by Chinese Clinical Trial Register record.
- 03 Feb 2012 New trial record